- Oncology and immunology focused Tiziana Life Sciences launched a public offering of American depositary shares, to advance its R&D programmes.

The securities would be issued in the US and have a nominal value £0.03 each on the Nasdaq Global Market.

Each ADS represented five ordinary shares in Tiziana.

Story provided by